RNA (ribonucleic acid) has become increasingly important in diagnostics and clinical approaches due to its diverse roles and potential applications. In diagnosis, RNA can be detected through reverse transcription-PCR (RT-PCR), in which DNA that is complementary (cDNA) is first created from reverse-transcribed RNA and subsequently amplified. This method is widely used in diagnosing RNA viruses like SARS-CoV-2. RNA sequencing (RNA-seq) allows for the quantification and profiling of RNA transcripts in a sample, providing insights into gene expression patterns. This can be crucial for diagnosing cancers or other diseases where gene expression changes are indicative. MicroRNAs, also referred to as small RNA molecules, play a part in the post-transcriptional regulation of gene expression. Technologies like CRISPR/Cas-based RNA detection methods (CRISPR diagnostics) are emerging for swift and accurate RNA detection sequences associated along with pathogens or specific disease markers. Antisense oligonucleotide therapeutics, mRNA vaccines (such the COVID-19 vaccines), and RNA-based clinical treatments like RNA interference (RNAi) are revolutionizing clinical illness treatment methods. mRNA vaccines instruct cells to produce proteins that trigger an immune response, protecting against infectious diseases. RNA sequencing and analysis are used to identify specific genetic mutations or aberrant gene expression patterns in cancers and other diseases. In summary, RNA is pivotal in diagnostics for detecting pathogens and biomarkers and in clinical approaches for developing therapies, predicting outcomes, and monitoring diseases. Its versatility and specificity make it a powerful tool in modern medicine, advancing personalized and precision healthcare.